Clinical Trials Logo

Clinical Trial Summary

To evaluate the safety and tolerability of LY2951742 given as single or multiple subcutaneous injection in healthy male subjects


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01337596
Study type Interventional
Source Eli Lilly and Company
Contact
Status Completed
Phase Phase 1
Start date April 2011
Completion date April 2012

See also
  Status Clinical Trial Phase
Completed NCT01547494 - A Nutritional Intervention for Migraines N/A
Recruiting NCT06022848 - Quantitative Sensory Testing and Occipital Nerve Stimulator N/A
Completed NCT01699009 - A Nutritional Intervention for Migraines-2 N/A
Completed NCT01813669 - Integrative Coping Group for Children N/A
Completed NCT03844412 - Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Phase 2
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Terminated NCT04201080 - A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250 Phase 1
Completed NCT00727974 - Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines
Completed NCT00700128 - Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals N/A
Completed NCT00195754 - A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488. Phase 3
Completed NCT01807234 - Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine Phase 4
Completed NCT02748577 - Pain Processing in Adults With Migraines N/A
Completed NCT00753493 - Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients Phase 1
Completed NCT00483704 - Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031) Phase 3